Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 3/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21799813 | 1.00 | CXCR4 (0.61) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB | |
| SCHEMBL21799944 | 1.00 | CXCR4 (0.61) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB | |
| SCHEMBL10706534 | 1.00 | CXCR4 (0.61) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB | |
| SCHEMBL10705415 | 1.00 | CXCR4 (0.61) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB | |
| SCHEMBL8502191 | 1.00 | CXCR4 (0.61) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB | |
| SCHEMBL542926 | 1.00 | CXCR4 (0.61) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB | |
| SCHEMBL21799929 | 1.00 | CXCR4 (0.61) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB | |
| SCHEMBL15066083 | 0.98 | CXCR4 (0.59) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB | |
| SCHEMBL15065482 | 0.98 | CXCR4 (0.59) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB | |
| SCHEMBL1097523 | 0.98 | CXCR4 (0.57) | CXCR4SMN1; SMN2KEAP1SIGMAR1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117247755-B | Adhesive, preparation method thereof and composite insulating paper | 比亚迪股份有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-117247755-A | Adhesive, preparation method thereof and composite insulating paper | 比亚迪股份有限公司 | 2023-12-19 | — | — | CN | claimed |
| EP-2797901-B1 | FORMATION OF HIGHER MOLECULAR WEIGHT CYCLIC POLYAMINE COMPOUNDS FROM CYCLIC POLYAMINE COMPOUNDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-05-10 | — | — | EP | claimed |
| US-9162995-B2 | Formation of higher molecular weight cyclic polyamine compounds from cyclic polyamine compounds | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-10-20 | — | — | US | claimed |
| US-20150011762-A1 | FORMATION OF HIGHER MOLECULAR WEIGHT CYCLIC POLYAMINE COMPOUNDS FROM CYCLIC POLYAMINE COMPOUNDS | DOW GLOBAL TECHNOLOGIES LLC | 2015-01-08 | — | — | US | claimed |
| CN-104136482-A | EPOXY COATING SYSTEMS USING POLYCYCLIC POLYAMINES AS EPOXY HARDENERS | DOW GLOBAL TECHNOLOGIES LLC | 2014-11-05 | — | — | CN | claimed |
| CN-117247755-B | Adhesive, preparation method thereof and composite insulating paper | 比亚迪股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-3623398-B1 | RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER | ASAHI CHEMICAL IND (JP) | 2024-08-28 | — | — | EP | disclosed |
| CN-117247755-A | Adhesive, preparation method thereof and composite insulating paper | 比亚迪股份有限公司 | 2023-12-19 | — | — | CN | disclosed |
| WO-2023071601-A1 | DESLORATADINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 天津市昕晨投资发展有限公司 | 2023-05-04 | — | — | WO | disclosed |
| WO-2023054272-A1 | PRINTING ORIGINAL PLATE FOR PHOTOSENSITIVE RESIN LETTERPRESS, AND PRINTING PLATE | 東洋紡株式会社 | 2023-04-06 | — | — | WO | disclosed |
| CN-110603273-B | Modified block copolymer, method for producing modified block copolymer, and resin composition | 旭化成株式会社 | 2022-10-14 | — | — | CN | disclosed |
| US-11124593-B2 | Modified block copolymer, method for producing modified block copolymer, and resin composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-09-21 | — | — | US | disclosed |
| US-4581454-A | USED AS CURING AGENTS FOR EPOXY RESINS | THE DOW CHEMICAL COMPANY (US) | 1986-04-08 | — | — | US | disclosed |
| EP-0136790-A2 | New additives for retarding setting of cement from methylenephosphonated aminohydrocarbylpiperazine-urea adducts | THE DOW CHEMICAL COMPANY (US) | 1985-04-10 | — | — | EP | disclosed |
| EP-0136015-A1 | New methylene phosphonic acid scale inhibitor compositions derived from aminohydrocarbylpiperazine-urea adducts | THE DOW CHEMICAL COMPANY (US) | 1985-04-03 | — | — | EP | disclosed |
| WO-1985001043-A1 | USE OF METHYLENE PHOSPHONIC ACID COMPOSITIONS DERIVED FROM AMINOHYDROCARBYLPIPERAZINEUREA ADDUCTS AS CEMENT RETARDERS | THE DOW CHEMICAL COMPANY (US) | 1985-03-14 | — | — | WO | disclosed |
| WO-1985001042-A1 | NEW METHYLENE PHOSPHONIC ACID SCALE INHIBITOR COMPOSITIONS DERIVED FROM AMINOHYDROCARBYLPIPERAZINE-UREA ADDUCTS | THE DOW CHEMICAL COMPANY (US) | 1985-03-14 | — | — | WO | disclosed |
| US-4220704-A | Water soluble photosensitive resin compositions comprising a polyamide or its salt | TOYOBO CO., LTD. (JP) | 1980-09-02 | — | — | US | disclosed |
| US-4145222-A | Water soluble photosensitive resin composition comprising a polyamide or its ammonium salt | TOYOBO CO., LTD. (JP) | 1979-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011762-A1 | FORMATION OF HIGHER MOLECULAR WEIGHT CYCLIC POLYAMINE COMPOUNDS FROM CYCLIC POLYAMINE COMPOUNDS | SRM, PCNA, SMS | CXCR4 4622/4885SMN1; SMN2 4450/4885KEAP1 1443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.